The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

AlzheimerResearch & Science

Research & Science EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer’s Prevention Trials

At a meeting of the EU/US/Clinical Trials in Alzheimer’s Disease (CTAD) Task Force in December 2016, an international group of investigators from industry, academia, and regulatory agencies reviewed lessons learned from ongoing and planned prevention trials, which will help guide… Continue Reading →

Plasma biomarker for Alzheimer’s disease: Are we ready now for clinical practice and drug trials?

This is a restricted content for our subscribers.

Research & Science What Have We Learned from Recent Alzheimer’s Trials? Perspective of the CTAD Task Force

Although the results were disappointing from two recent clinical trials of amyloid-targeting drugs in mild-to-moderate AD, the trials provided information that will be important for future studies, according to the EU-US CTAD Task Force, which met in November 2017 to… Continue Reading →

© 2019 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑